SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-325899
Filing Date
2012-07-31
Accepted
2012-07-31 16:19:17
Documents
3
Period of Report
2012-09-06
Effectiveness Date
2012-07-31

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d388489ddef14a.htm DEF 14A 280737
2 GRAPHIC g388489image_1.jpg GRAPHIC 9668
3 GRAPHIC g388489sig.jpg GRAPHIC 3485
  Complete submission text file 0001193125-12-325899.txt   300342
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-52228 | Film No.: 12997133
SIC: 8731 Services-Commercial Physical & Biological Research